David Prime

965 total citations
21 papers, 763 citations indexed

About

David Prime is a scholar working on Pulmonary and Respiratory Medicine, Pharmaceutical Science and Physiology. According to data from OpenAlex, David Prime has authored 21 papers receiving a total of 763 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 7 papers in Pharmaceutical Science and 6 papers in Physiology. Recurrent topics in David Prime's work include Inhalation and Respiratory Drug Delivery (21 papers), Drug Solubulity and Delivery Systems (6 papers) and Asthma and respiratory diseases (6 papers). David Prime is often cited by papers focused on Inhalation and Respiratory Drug Delivery (21 papers), Drug Solubulity and Delivery Systems (6 papers) and Asthma and respiratory diseases (6 papers). David Prime collaborates with scholars based in United Kingdom, United States and Sweden. David Prime's co-authors include Hassan Larhrib, Gary P. Martin, Christopher Marriott, Melanie Hamilton, P.K.P. Burnell, Cheng Pang, Richard Leggett, Stephen Charles, Lars Borgström and Snow Stolnik and has published in prestigious journals such as Advanced Drug Delivery Reviews, CHEST Journal and International Journal of Pharmaceutics.

In The Last Decade

David Prime

20 papers receiving 728 citations

Peers

Countries citing papers authored by David Prime

Since Specialization

Citations

This map shows the geographic impact of David Prime's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Prime with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Prime more than expected).

Fields of papers citing papers by David Prime

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Prime. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Prime. The network helps show where David Prime may publish in the future.

Co-authorship network of co-authors of David Prime

This figure shows the co-authorship network connecting the top 25 collaborators of David Prime. A scholar is included among the top collaborators of David Prime based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Prime. David Prime is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Charged Particle Dynamics in Dry Powder Inhalers 2025 ·Molecular Pharmaceutics ·(unknown), (unknown), Melanie Hamilton, Cheng Pang, David Prime, A. J. Stace, Elena Besley	0
2	iBCS: 4. Application of the Inhalation Biopharmaceutics Classification System to the Development of Orally Inhaled Drug Products 2025 ·Molecular Pharmaceutics ·Ben Forbes, Per Bäckman, Antonio Cabal, Andrew R. Clark, Carsten Ehrhardt, (unknown), Anthony J. Hickey, Günther Hochhaus, Wenlei Jiang, Stavros C. Kassinos, Philip J. Kuehl, Bo Olsson, David Prime, Yoen‐Ju Son, (unknown), (unknown), (unknown)	3
3	In Vitro Drug Delivery of a Fixed-Dose Combination of Fluticasone Furoate/Umeclidinium/Vilanterol from a Dry Powder Inhaler 2023 ·Journal of Aerosol Medicine and Pulmonary Drug Delivery ·Melanie Hamilton, Martin Anderson, Rajiv Dhand, (unknown), David Prime, Edward C. Taylor	4
4	iBCS: 3. A Biopharmaceutics Classification System for Orally Inhaled Drug Products 2023 ·Molecular Pharmaceutics ·(unknown), Per Bäckman, Antonio Cabal, Andrew R. Clark, Carsten Ehrhardt, Ben Forbes, Anthony J. Hickey, Günther Hochhaus, Wenlei Jiang, Stavros C. Kassinos, Philip J. Kuehl, David Prime, Yoen‐Ju Son, (unknown), (unknown), (unknown)	8
5	iBCS: 2. Mechanistic Modeling of Pulmonary Availability of Inhaled Drugs versus Critical Product Attributes 2022 ·Molecular Pharmaceutics ·Per Bäckman, Antonio Cabal, Andrew R. Clark, Carsten Ehrhardt, Ben Forbes, (unknown), Anthony J. Hickey, Günther Hochhaus, Wenlei Jiang, Stavros C. Kassinos, Philip J. Kuehl, David Prime, Yoen‐Ju Son, (unknown), (unknown), (unknown)	16
6	iBCS: 1. Principles and Framework of an Inhalation-Based Biopharmaceutics Classification System 2022 ·Molecular Pharmaceutics ·(unknown), Per Bäckman, Antonio Cabal, Andrew R. Clark, Carsten Ehrhardt, Ben Forbes, Anthony J. Hickey, Günther Hochhaus, Wenlei Jiang, Stavros C. Kassinos, Philip J. Kuehl, David Prime, Yoen‐Ju Son, (unknown), (unknown), (unknown)	23
7	Using Polar Ion-Pairs to Control Drug Delivery to the Airways of the Lungs 2020 ·Molecular Pharmaceutics ·(unknown), (unknown), (unknown), David Prime, David J. Barlow, Ben Forbes, Stuart A. Jones	8
8	In-vitro product performance of fluticasone furoate (FF)/umeclidinium (UMEC)/vilanterol (VI) delivered from a dry powder inhaler (DPI) using the Electronic Lung (EL) to replicate patient inhalation profiles 2019 ·David Prime, Melanie Hamilton, Edward Taylor	1
9	In vitro investigation on the impact of airway mucus on drug dissolution and absorption at the air-epithelium interface in the lungs 2019 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown), Safar M. Alqahtani, (unknown), David Prime, Snow Stolnik, Cynthia Bosquillon	41
10	CONSISTENCY OF DOSE DELIVERY OF FLUTICASONE FUROATE (FF)/UMECLIDINIUM (UMEC)/VILANTEROL (VI) ACROSS PATIENT RELEVANT INHALATION FLOW RATES FROM A DRY-POWDER INHALER (DPI) 2019 ·CHEST Journal ·David Prime, Melanie Hamilton, (unknown)	1
11	In Vitro Dosing Performance of the ELLIPTA ^® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™) 2015 ·Journal of Aerosol Medicine and Pulmonary Drug Delivery ·Melanie Hamilton, Richard Leggett, Cheng Pang, Stephen Charles, (unknown), David Prime	46
12	Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA ^® Dry Powder Inhaler 2015 ·Journal of Aerosol Medicine and Pulmonary Drug Delivery ·David Prime, Wilfried De Backer, Melanie Hamilton, Anthony Cahn, Andrew Preece, Dennis Kelleher, Amanda Baines, Alison Moore, Noushin Brealey, (unknown)	49
13	Development of an In Vitro Model to Assess Deposition of Aerosol Particles in a Representative Replica of the Rat's Respiratory Tract 2012 ·Journal of Aerosol Medicine and Pulmonary Drug Delivery ·(unknown), David Prime, P.K.P. Burnell, Petra Högger	5
14	Comparison Of Inhalation Profiles Through A Novel Dry Powder Inhaler (nDPI) And Lung Function Measurements For Healthy Subjects, Asthma And Chronic Obstructive Pulmonary Disease (COPD) Patients 2012 ·David Prime, Wilfried De Backer, Melanie Hamilton, Anthony Cahn, Andrew Preece, Dennis Kelleher, (unknown)	5
15	Studies of the Human Oropharyngeal Airspaces Using Magnetic Resonance Imaging IV—The Oropharyngeal Retention Effect for Four Inhalation Delivery Systems 2007 ·Journal of Aerosol Medicine ·P.K.P. Burnell, Lars Asking, Lars Borgström, (unknown), Bo Olsson, David Prime, (unknown)	51
16	Characterisation and deposition studies of engineered lactose crystals with potential for use as a carrier for aerosolised salbutamol sulfate from dry powder inhalers 2003 ·European Journal of Pharmaceutical Sciences ·Hassan Larhrib, Gary P. Martin, David Prime, Christopher Marriott	68
17	The influence of carrier and drug morphology on drug delivery from dry powder formulations 2003 ·International Journal of Pharmaceutics ·Hassan Larhrib, Gary P. Martin, Christopher Marriott, David Prime	140
18	Latest advances in the development of dry powder inhalers 2000 ·PubMed ·(unknown), (unknown), David Prime, (unknown)	95
19	A Critical Comparison of the Dose Delivery Characteristics of Four Alternative Inhalation Devices Delivering Salbutamol: Pressurized Metered Dose Inhaler, Diskus Inhaler, Diskhaler Inhaler, and Turbuhaler Inhaler 1999 ·Journal of Aerosol Medicine ·David Prime, (unknown), (unknown), (unknown)	54
20	Review of dry powder inhalers 1997 ·Advanced Drug Delivery Reviews ·David Prime	143

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact